Share

February 25, 2014; 82 (8) Special Article

Summary of evidence-based guideline update: Prevention of stroke in nonvalvular atrial fibrillation

Report of the Guideline Development Subcommittee of the American Academy of Neurology

Antonio Culebras, Steven R. Messé, Seemant Chaturvedi, Carlos S. Kase, Gary Gronseth
First published February 24, 2014, DOI: https://doi.org/10.1212/WNL.0000000000000145
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
30138

Share

This article has a correction. Please see:

Article Figures & Data

Figures

  • Figure 1
    Figure 1 Proportion of patients with ischemic stroke identified with nonvalvular atrial fibrillation, by study

    Studies sorted by monitoring duration. CI = confidence interval; ELR = event loop recorder; HM = Holter monitoring; inptTele = continuous inpatient telemetry; MCOT = mobile cardiac outpatient telemetry; phoneEKG = outpatient transtelephonic EKG monitoring; sEKG = serial EKG; sELR = serial event loop recordings.

  • Figure 2
    Figure 2 Relative risk reductions of various outcomes in patients with nonvalvular atrial fibrillation receiving various antithrombotic regimens as compared with warfarin or its derivatives

    Acenocoum = acenocoumarol; ASA = acetylsalicylic acid; CI = confidence interval.

Additional Files

  • Data Supplement

    Full-length article, references; one PDF file and one Microsoft Word file.

    Neurology® data supplements are not copyedited before publication. Published editorials and translations have been copyedited.
    © 2014 American Academy of Neurology.

    Files in this Data Supplement:

  • PODCAST

    PODCAST

    • Korean Translation

      Neurology® data supplements are not copyedited before publication. Published editorials and translations have been copyedited.
      © 2014 American Academy of Neurology.

      Files in this Data Supplement:

    Disputes & Debates: Rapid online correspondence

    Comment

    NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

    • Stay timely. Submit only on articles published within the last 8 weeks.
    • Do not be redundant. Read any comments already posted on the article prior to submission.
    • 200 words maximum.
    • 5 references maximum. Reference 1 must be the article on which you are commenting.
    • 5 authors maximum. Exception: replies can include all original authors of the article.
    • Submitted comments are subject to editing and editor review prior to posting.

    More guidelines and information on Disputes & Debates

    Compose Comment

    More information about text formats

    Plain text

    • No HTML tags allowed.
    • Web page addresses and e-mail addresses turn into links automatically.
    • Lines and paragraphs break automatically.
    Author Information
    NOTE: The first author must also be the corresponding author of the comment.
    First or given name, e.g. 'Peter'.
    Your last, or family, name, e.g. 'MacMoody'.
    Your email address, e.g. higgs-boson@gmail.com
    Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
    Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
    Publishing Agreement
    NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

    Vertical Tabs

    You May Also be Interested in

    Back to top
    Advertisement

    Related Articles

    Topics Discussed

    Alert Me